| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC3482 |
| Trial ID | NCT05907603 |
| Disease | Hematologic Cancer | Hematologic Disease | Neoplasm |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | RD13-02 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML) |
| Year | 2023 |
| Country | China |
| Company sponsor | Kai Lin Xu, MD |
| Other ID(s) | BHCT-RD13-02-06 |
| Cohort 1 | |||||||||
|
|||||||||